MAS
$61.75
Masco Corporation provides home improvement and building products in North America, Europe, and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Masco Corporation provides home improvement and building products in North America, Europe, and internationally. The company's Plumbing Products segment offers faucets, showerheads, handheld showers, valves, bath hardware and accessories, bathing uni...
Recent News
1 Profitable Stock Worth Your Attention and 2 We Brush Off
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Why Is Masco (MAS) Down 18.3% Since Last Earnings Report?
Masco (MAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Home Construction Materials Stocks Q4 In Review: Masco (NYSE:MAS) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Masco (NYSE:MAS) and the rest of the home construction materials stocks fared in Q4.
Argan (AGX) Soars 12.6%: Is Further Upside Left in the Stock?
Argan (AGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Assessing Masco (MAS) Valuation After Recent Share Price Pullback And Mixed Short Term Returns
Masco (MAS) has come onto investors’ radar after recent share moves, with the stock down about 2.5% over the past week but higher over the past month and the past three months. See our latest analysis for Masco. While the latest 1-day and 7-day share price returns have been negative, Masco’s 30-day and 90-day share price returns are positive, and its multi year total shareholder returns show that long term holders have still seen gains. If Masco’s recent pullback has you thinking about what...